BRAIN Biotech AG (BNN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -2.326x

Based on the latest financial reports, BRAIN Biotech AG (BNN) has a cash flow conversion efficiency ratio of -2.326x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.28 Million ≈ $-5.01 Million USD) by net assets (€1.84 Million ≈ $2.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BRAIN Biotech AG market cap and net worth for the company's overall valuation and market capitalisation.

BRAIN Biotech AG - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how BRAIN Biotech AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BRAIN Biotech AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BRAIN Biotech AG ranked by their cash flow conversion efficiency. Explore BNN cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Futuretech II Acquisition Corp NASDAQ:FTII	-3.681x
Gogoro Inc NASDAQ:GGR	0.204x
Drb Industrial KO:163560	0.027x
Innox Corporation KQ:088390	-0.009x
Ailleron S.A. WAR:ALL	0.037x
Prolific Technology TWO:6233	0.010x
Australian Vanadium Ltd AU:AVL	-0.040x
Matriks Bilgi Dagitim Hizmetleri AS IS:MTRKS	0.108x

Annual Cash Flow Conversion Efficiency for BRAIN Biotech AG (2012–2025)

The table below shows the annual cash flow conversion efficiency of BRAIN Biotech AG from 2012 to 2025. View BRAIN Biotech AG (BNN) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	€1.84 Million ≈ $2.15 Million	€-9.23 Million ≈ $-10.79 Million	-5.015x	-1843.65%
2024-09-30	€13.89 Million ≈ $16.23 Million	€-3.58 Million ≈ $-4.19 Million	-0.258x	-40.78%
2023-09-30	€23.01 Million ≈ $26.91 Million	€-4.22 Million ≈ $-4.93 Million	-0.183x	-322.69%
2022-09-30	€34.25 Million ≈ $40.04 Million	€-1.49 Million ≈ $-1.74 Million	-0.043x	+53.57%
2021-09-30	€41.83 Million ≈ $48.90 Million	€-3.91 Million ≈ $-4.57 Million	-0.093x	+48.79%
2020-09-30	€26.14 Million ≈ $30.56 Million	€-4.77 Million ≈ $-5.57 Million	-0.182x	+7.80%
2019-09-30	€17.09 Million ≈ $19.98 Million	€-3.38 Million ≈ $-3.95 Million	-0.198x	-11.84%
2018-09-30	€30.64 Million ≈ $35.82 Million	€-5.42 Million ≈ $-6.33 Million	-0.177x	-45.48%
2017-09-30	€47.36 Million ≈ $55.37 Million	€-5.76 Million ≈ $-6.73 Million	-0.122x	+62.31%
2016-09-30	€26.93 Million ≈ $31.48 Million	€-8.68 Million ≈ $-10.15 Million	-0.322x	+54.88%
2015-09-30	€5.76 Million ≈ $6.73 Million	€-4.11 Million ≈ $-4.81 Million	-0.715x	-153.56%
2014-09-30	€13.85 Million ≈ $16.19 Million	€-3.90 Million ≈ $-4.56 Million	-0.282x	-2.26%
2013-09-30	€17.59 Million ≈ $20.57 Million	€-4.85 Million ≈ $-5.67 Million	-0.276x	+43.22%
2012-09-30	€12.12 Million ≈ $14.17 Million	€-5.89 Million ≈ $-6.88 Million	-0.485x	--

About BRAIN Biotech AG

XETRA:BNN Germany Specialty Chemicals

Market Cap

$71.01 Million

€60.74 Million EUR

Market Cap Rank

#21874 Global

#1937 in Germany

Share Price

€2.78

Change (1 day)

-0.71%

52-Week Range

€2.09 - €3.66

All Time High

€27.50